Physicians' Academy for Cardiovascular Education

Anacetrapib reduces non-HDL-cholesterolvia reducing PCSK9 and enhancing hepatic remnant clearance

June 18, 2015

Presentation prepared and held by Dr Yanan Wang (Leiden, The Netherlands) in Clinical Breakthroughs: A plethora of new therapeutic targets, Sunday, May 24, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images
2015_ISA_266_ANA_and_lipid_metabolism_YW.pdf (2,4MB)2015_ISA_266_ANA_and_lipid_metabolism_YW.pdf (2,4MB)